Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $29.4000 (-5.77%) ($29.4000 - $31.1000) on Thu. Feb. 23, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.65% (three month average) | RSI | 71 | Latest Price | $29.4000(-5.77%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.3% a day on average for past five trading days. | Weekly Trend | CAPR advances 12% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWI(7%) PEJ(7%) SKYY(7%) XLF(7%) ARKK(6%) | Factors Impacting CAPR price | CAPR will decline at least -2.325% in a week (0% probabilities). GDX(-7%) TLT(-6%) SIL(-6%) GLD(-6%) VIXM(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.325% (StdDev 4.65%) | Hourly BBV | 0 () | Intraday Trend | -4.5% | | | |
|
5 Day Moving Average | $30.84(-4.67%) | 10 Day Moving Average | $29.82(-1.41%) | 20 Day Moving Average | $26.95(9.09%) | To recent high | -8.1% | To recent low | 34.9% | Market Cap | $579m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |